nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—Pulmonary toxicity—Fludarabine—lymphatic system cancer	0.0718	0.0935	CcSEcCtD
Dronedarone—Pulmonary toxicity—Carmustine—lymphatic system cancer	0.0459	0.0598	CcSEcCtD
Dronedarone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0412	0.177	CbGbCtD
Dronedarone—Pulmonary fibrosis—Fludarabine—lymphatic system cancer	0.0371	0.0483	CcSEcCtD
Dronedarone—CYP3A4—Cytarabine—lymphatic system cancer	0.0358	0.154	CbGbCtD
Dronedarone—CYP3A4—Teniposide—lymphatic system cancer	0.0353	0.152	CbGbCtD
Dronedarone—ALB—Methotrexate—lymphatic system cancer	0.0328	0.141	CbGbCtD
Dronedarone—ABCB1—Vincristine—lymphatic system cancer	0.0283	0.122	CbGbCtD
Dronedarone—Pulmonary fibrosis—Bleomycin—lymphatic system cancer	0.0272	0.0354	CcSEcCtD
Dronedarone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0247	0.106	CbGbCtD
Dronedarone—Pulmonary fibrosis—Carmustine—lymphatic system cancer	0.0237	0.0309	CcSEcCtD
Dronedarone—Pulmonary toxicity—Methotrexate—lymphatic system cancer	0.0213	0.0277	CcSEcCtD
Dronedarone—Hypomagnesaemia—Bleomycin—lymphatic system cancer	0.0188	0.0245	CcSEcCtD
Dronedarone—ABCB1—Methotrexate—lymphatic system cancer	0.0172	0.0739	CbGbCtD
Dronedarone—CYP3A4—Vincristine—lymphatic system cancer	0.017	0.0731	CbGbCtD
Dronedarone—Interstitial lung disease—Bleomycin—lymphatic system cancer	0.0169	0.022	CcSEcCtD
Dronedarone—Interstitial lung disease—Carmustine—lymphatic system cancer	0.0147	0.0192	CcSEcCtD
Dronedarone—Interstitial lung disease—Mitoxantrone—lymphatic system cancer	0.0137	0.0178	CcSEcCtD
Dronedarone—Cardiac failure congestive—Fludarabine—lymphatic system cancer	0.013	0.017	CcSEcCtD
Dronedarone—Cardiac failure—Fludarabine—lymphatic system cancer	0.0121	0.0158	CcSEcCtD
Dronedarone—Pulmonary fibrosis—Methotrexate—lymphatic system cancer	0.011	0.0143	CcSEcCtD
Dronedarone—Leukocytoclastic vasculitis—Methotrexate—lymphatic system cancer	0.00985	0.0128	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0093	0.0121	CcSEcCtD
Dronedarone—Pneumonia—Fludarabine—lymphatic system cancer	0.00917	0.0119	CcSEcCtD
Dronedarone—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00897	0.0117	CcSEcCtD
Dronedarone—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00872	0.0114	CcSEcCtD
Dronedarone—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00776	0.0101	CcSEcCtD
Dronedarone—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00721	0.00939	CcSEcCtD
Dronedarone—Hypokalaemia—Carmustine—lymphatic system cancer	0.00689	0.00898	CcSEcCtD
Dronedarone—Interstitial lung disease—Methotrexate—lymphatic system cancer	0.00683	0.00889	CcSEcCtD
Dronedarone—Pneumonia—Bleomycin—lymphatic system cancer	0.00672	0.00876	CcSEcCtD
Dronedarone—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00659	0.00859	CcSEcCtD
Dronedarone—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00641	0.00834	CcSEcCtD
Dronedarone—Pruritus—Mechlorethamine—lymphatic system cancer	0.00635	0.00827	CcSEcCtD
Dronedarone—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00614	0.008	CcSEcCtD
Dronedarone—Pneumonia—Carmustine—lymphatic system cancer	0.00587	0.00764	CcSEcCtD
Dronedarone—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00581	0.00757	CcSEcCtD
Dronedarone—Vomiting—Mechlorethamine—lymphatic system cancer	0.00571	0.00743	CcSEcCtD
Dronedarone—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0057	0.00743	CcSEcCtD
Dronedarone—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.0057	0.00743	CcSEcCtD
Dronedarone—Rash—Mechlorethamine—lymphatic system cancer	0.00566	0.00737	CcSEcCtD
Dronedarone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00565	0.00736	CcSEcCtD
Dronedarone—Pneumonia—Vincristine—lymphatic system cancer	0.0056	0.0073	CcSEcCtD
Dronedarone—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00546	0.00711	CcSEcCtD
Dronedarone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00541	0.00705	CcSEcCtD
Dronedarone—Nausea—Mechlorethamine—lymphatic system cancer	0.00533	0.00694	CcSEcCtD
Dronedarone—Abdominal pain—Teniposide—lymphatic system cancer	0.00523	0.00681	CcSEcCtD
Dronedarone—Erythema—Bleomycin—lymphatic system cancer	0.00522	0.0068	CcSEcCtD
Dronedarone—Dyspepsia—Fludarabine—lymphatic system cancer	0.00512	0.00667	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00502	0.00654	CcSEcCtD
Dronedarone—Fatigue—Fludarabine—lymphatic system cancer	0.00501	0.00653	CcSEcCtD
Dronedarone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00496	0.00646	CcSEcCtD
Dronedarone—Vasculitis—Methotrexate—lymphatic system cancer	0.00495	0.00645	CcSEcCtD
Dronedarone—Asthenia—Teniposide—lymphatic system cancer	0.00475	0.00618	CcSEcCtD
Dronedarone—Pruritus—Teniposide—lymphatic system cancer	0.00468	0.0061	CcSEcCtD
Dronedarone—Cardiac disorder—Vincristine—lymphatic system cancer	0.00464	0.00604	CcSEcCtD
Dronedarone—Erythema—Carmustine—lymphatic system cancer	0.00456	0.00594	CcSEcCtD
Dronedarone—Angiopathy—Vincristine—lymphatic system cancer	0.00454	0.00591	CcSEcCtD
Dronedarone—Diarrhoea—Teniposide—lymphatic system cancer	0.00453	0.0059	CcSEcCtD
Dronedarone—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00451	0.00587	CcSEcCtD
Dronedarone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00426	0.00555	CcSEcCtD
Dronedarone—Erythema—Mitoxantrone—lymphatic system cancer	0.00424	0.00552	CcSEcCtD
Dronedarone—Vomiting—Teniposide—lymphatic system cancer	0.00421	0.00548	CcSEcCtD
Dronedarone—Asthenia—Fludarabine—lymphatic system cancer	0.00417	0.00543	CcSEcCtD
Dronedarone—Rash—Teniposide—lymphatic system cancer	0.00417	0.00543	CcSEcCtD
Dronedarone—Dermatitis—Teniposide—lymphatic system cancer	0.00417	0.00543	CcSEcCtD
Dronedarone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00415	0.00541	CcSEcCtD
Dronedarone—Pruritus—Fludarabine—lymphatic system cancer	0.00411	0.00536	CcSEcCtD
Dronedarone—Diarrhoea—Fludarabine—lymphatic system cancer	0.00398	0.00518	CcSEcCtD
Dronedarone—Nausea—Teniposide—lymphatic system cancer	0.00393	0.00512	CcSEcCtD
Dronedarone—Vomiting—Fludarabine—lymphatic system cancer	0.0037	0.00482	CcSEcCtD
Dronedarone—Rash—Fludarabine—lymphatic system cancer	0.00367	0.00478	CcSEcCtD
Dronedarone—Dermatitis—Fludarabine—lymphatic system cancer	0.00366	0.00477	CcSEcCtD
Dronedarone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00355	0.00463	CcSEcCtD
Dronedarone—Nervous system disorder—Vincristine—lymphatic system cancer	0.00348	0.00454	CcSEcCtD
Dronedarone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00346	0.00451	CcSEcCtD
Dronedarone—Nausea—Fludarabine—lymphatic system cancer	0.00345	0.0045	CcSEcCtD
Dronedarone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00336	0.00438	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00321	0.00418	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00307	0.00399	CcSEcCtD
Dronedarone—Fatigue—Vincristine—lymphatic system cancer	0.00306	0.00399	CcSEcCtD
Dronedarone—Asthenia—Bleomycin—lymphatic system cancer	0.00306	0.00398	CcSEcCtD
Dronedarone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00305	0.00397	CcSEcCtD
Dronedarone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00304	0.00396	CcSEcCtD
Dronedarone—Pruritus—Bleomycin—lymphatic system cancer	0.00302	0.00393	CcSEcCtD
Dronedarone—Fatigue—Mitoxantrone—lymphatic system cancer	0.00298	0.00389	CcSEcCtD
Dronedarone—Abdominal pain—Carmustine—lymphatic system cancer	0.00294	0.00383	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0029	0.00378	CcSEcCtD
Dronedarone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00283	0.00368	CcSEcCtD
Dronedarone—Abdominal pain—Vincristine—lymphatic system cancer	0.00281	0.00366	CcSEcCtD
Dronedarone—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00277	0.0036	CcSEcCtD
Dronedarone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00273	0.00356	CcSEcCtD
Dronedarone—Pneumonia—Methotrexate—lymphatic system cancer	0.00272	0.00354	CcSEcCtD
Dronedarone—Vomiting—Bleomycin—lymphatic system cancer	0.00271	0.00353	CcSEcCtD
Dronedarone—Rash—Bleomycin—lymphatic system cancer	0.00269	0.0035	CcSEcCtD
Dronedarone—Dermatitis—Bleomycin—lymphatic system cancer	0.00269	0.0035	CcSEcCtD
Dronedarone—Asthenia—Carmustine—lymphatic system cancer	0.00267	0.00348	CcSEcCtD
Dronedarone—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00256	0.00333	CcSEcCtD
Dronedarone—Asthenia—Vincristine—lymphatic system cancer	0.00255	0.00332	CcSEcCtD
Dronedarone—Diarrhoea—Carmustine—lymphatic system cancer	0.00255	0.00332	CcSEcCtD
Dronedarone—Nausea—Bleomycin—lymphatic system cancer	0.00253	0.0033	CcSEcCtD
Dronedarone—Asthenia—Mitoxantrone—lymphatic system cancer	0.00248	0.00323	CcSEcCtD
Dronedarone—Diarrhoea—Vincristine—lymphatic system cancer	0.00243	0.00317	CcSEcCtD
Dronedarone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00237	0.00308	CcSEcCtD
Dronedarone—Vomiting—Carmustine—lymphatic system cancer	0.00237	0.00308	CcSEcCtD
Dronedarone—Rash—Carmustine—lymphatic system cancer	0.00235	0.00306	CcSEcCtD
Dronedarone—Dermatitis—Carmustine—lymphatic system cancer	0.00234	0.00305	CcSEcCtD
Dronedarone—Vomiting—Vincristine—lymphatic system cancer	0.00226	0.00294	CcSEcCtD
Dronedarone—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00225	0.00293	CcSEcCtD
Dronedarone—Rash—Vincristine—lymphatic system cancer	0.00224	0.00292	CcSEcCtD
Dronedarone—Dermatitis—Vincristine—lymphatic system cancer	0.00224	0.00291	CcSEcCtD
Dronedarone—Nausea—Carmustine—lymphatic system cancer	0.00221	0.00288	CcSEcCtD
Dronedarone—Angiopathy—Methotrexate—lymphatic system cancer	0.0022	0.00287	CcSEcCtD
Dronedarone—Vomiting—Mitoxantrone—lymphatic system cancer	0.0022	0.00287	CcSEcCtD
Dronedarone—Immune system disorder—Methotrexate—lymphatic system cancer	0.00219	0.00285	CcSEcCtD
Dronedarone—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00219	0.00285	CcSEcCtD
Dronedarone—Rash—Mitoxantrone—lymphatic system cancer	0.00218	0.00284	CcSEcCtD
Dronedarone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00218	0.00284	CcSEcCtD
Dronedarone—Erythema—Methotrexate—lymphatic system cancer	0.00211	0.00275	CcSEcCtD
Dronedarone—Nausea—Vincristine—lymphatic system cancer	0.00211	0.00275	CcSEcCtD
Dronedarone—Dysgeusia—Methotrexate—lymphatic system cancer	0.00207	0.00269	CcSEcCtD
Dronedarone—Nausea—Mitoxantrone—lymphatic system cancer	0.00205	0.00268	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00179	0.00233	CcSEcCtD
Dronedarone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00172	0.00225	CcSEcCtD
Dronedarone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00169	0.0022	CcSEcCtD
Dronedarone—Skin disorder—Methotrexate—lymphatic system cancer	0.00167	0.00218	CcSEcCtD
Dronedarone—Dyspepsia—Methotrexate—lymphatic system cancer	0.00152	0.00198	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00149	0.00194	CcSEcCtD
Dronedarone—Fatigue—Methotrexate—lymphatic system cancer	0.00149	0.00194	CcSEcCtD
Dronedarone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00141	0.00184	CcSEcCtD
Dronedarone—Abdominal pain—Methotrexate—lymphatic system cancer	0.00136	0.00177	CcSEcCtD
Dronedarone—Asthenia—Methotrexate—lymphatic system cancer	0.00124	0.00161	CcSEcCtD
Dronedarone—Pruritus—Methotrexate—lymphatic system cancer	0.00122	0.00159	CcSEcCtD
Dronedarone—Diarrhoea—Methotrexate—lymphatic system cancer	0.00118	0.00154	CcSEcCtD
Dronedarone—Vomiting—Methotrexate—lymphatic system cancer	0.0011	0.00143	CcSEcCtD
Dronedarone—Rash—Methotrexate—lymphatic system cancer	0.00109	0.00142	CcSEcCtD
Dronedarone—Dermatitis—Methotrexate—lymphatic system cancer	0.00109	0.00141	CcSEcCtD
Dronedarone—Nausea—Methotrexate—lymphatic system cancer	0.00102	0.00133	CcSEcCtD
